Advertisement
UK markets open in 2 hours 36 minutes

  • NIKKEI 225

    37,690.47
    -769.61 (-2.00%)
     

  • HANG SENG

    17,295.93
    +94.66 (+0.55%)
     

  • CRUDE OIL

    82.86
    +0.05 (+0.06%)
     

  • GOLD FUTURES

    2,325.80
    -12.60 (-0.54%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,446.85
    -2,109.63 (-3.94%)
     

  • CMC Crypto 200

    1,387.15
    -36.95 (-2.59%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Analysts’ Recommendations for Arrowhead and Its Peers

Kenneth Smith
Updated
Analysts’ Recommendations for Arrowhead and Its Peers

Incorporated in Delaware, Arrowhead Pharmaceuticals (ARWR) is focused on developing medicines for treating intractable diseases by silencing the genes that cause them. The therapies developed by Arrowhead make use of a broad portfolio of RNA chemistries and efficient modes of delivery to trigger an RNA interference mechanism that induces the rapid and durable knockdown of the target genes. RNA interference or (RNAi) is a mechanism that inhibits the expression of a specific gene.

Continue reading